Obesity | Evernorth

Obesity

Article

Study: Cardiodiabesity prevention key to improving health outcomes and lowering costs

The Evernorth Research Institute analyzed aggregated and anonymized data of almost 5 million insured individuals to understand the prevalence of "cardiodiabesity" — a condition which encompasses cardi...

September 07, 23

Article

Designing plans to manage comorbid conditions

Health plans that address and manage complex chronic conditions such as cardiovascular disease, obesity, and diabetes have a competitive advantage.

Daniel Chambers, PharmD, August 25, 23

Article

Tipping the scales to effectively treat obesity

The promise and challenges of semaglutide, a new therapy for weight loss

Christine Gilroy, MD, MSPH, August 02, 23

Article

Addressing obesity in the workplace

As more people turn to diabetes medication to manage their weight, obesity has become a pressing concern for employers.

Christine Gilroy, MD, MSPH, July 26, 23

Video

Clinically Speaking: GLP-1s Medications 101

GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population in the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...

Christine Gilroy, MD, MSPH, July 25, 23

Article

Clinically Speaking: Cardiodiabesity 101

More than half of U.S. adults suffer from cardiovascular disease, diabetes or obesity and a growing number experience all three. Plan sponsors can take action to address this increasingly complex chal...

Christine Gilroy, MD, MSPH, July 13, 23